These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10920073)
21. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081 [TBL] [Abstract][Full Text] [Related]
23. In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes. Vecchietti S; Grandi E; Severi S; Rivolta I; Napolitano C; Priori SG; Cavalcanti S Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H56-65. PubMed ID: 16980337 [TBL] [Abstract][Full Text] [Related]
24. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit. Makita N; Shirai N; Wang DW; Sasaki K; George AL; Kanno M; Kitabatake A Circulation; 2000 Jan 4-11; 101(1):54-60. PubMed ID: 10618304 [TBL] [Abstract][Full Text] [Related]
25. A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome. Makita N; Shirai N; Nagashima M; Matsuoka R; Yamada Y; Tohse N; Kitabatake A FEBS Lett; 1998 Feb; 423(1):5-9. PubMed ID: 9506831 [TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism for an inherited cardiac arrhythmia. Bennett PB; Yazawa K; Makita N; George AL Nature; 1995 Aug; 376(6542):683-5. PubMed ID: 7651517 [TBL] [Abstract][Full Text] [Related]
27. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome. Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658 [TBL] [Abstract][Full Text] [Related]
37. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Clancy CE; Rudy Y Circulation; 2002 Mar; 105(10):1208-13. PubMed ID: 11889015 [TBL] [Abstract][Full Text] [Related]
38. Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data. Chorin E; Hu D; Antzelevitch C; Hochstadt A; Belardinelli L; Zeltser D; Barajas-Martinez H; Rozovski U; Rosso R; Adler A; Benhorin J; Viskin S Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733495 [TBL] [Abstract][Full Text] [Related]
39. Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels. Tateyama M; Kurokawa J; Terrenoire C; Rivolta I; Kass RS Circulation; 2003 Jul; 107(25):3216-22. PubMed ID: 12796143 [TBL] [Abstract][Full Text] [Related]
40. Mutations in cardiac sodium channels: clinical implications. Liu H; Clancy C; Cormier J; Kass R Am J Pharmacogenomics; 2003; 3(3):173-9. PubMed ID: 12814325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]